[8-K] SBC Medical Group Holdings Incorporated Reports Material Event
SBC Medical Group Holdings Incorporated furnished a press release and an investor presentation reporting results for the quarter ended June 30, 2025. The press release is included as Exhibit 99.1 and the investor presentation as Exhibit 99.2, with the presentation available on the company website at https://sbc-holdings.com/en/ir/ir-presentation. The report specifies these items are furnished, not filed under the Exchange Act and therefore are not subject to Section 18 liabilities. The company identifies as an emerging growth company and lists its common stock (SBC) and redeemable warrants (SBCWW) on The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated ha diffuso un comunicato stampa e una presentazione per gli investitori con i risultati del trimestre chiuso al 30 giugno 2025. Il comunicato 猫 incluso come Exhibit 99.1 e la presentazione come Exhibit 99.2, con la presentazione disponibile sul sito della societ脿 all'indirizzo https://sbc-holdings.com/en/ir/ir-presentation. Il rapporto specifica che questi documenti sono forniti, non depositati ai sensi dell'Exchange Act e pertanto non sono soggetti alle responsabilit脿 previste dalla Section 18. La societ脿 si identifica come emerging growth company e registra le proprie azioni ordinarie (SBC) e i warrant rimborsabili (SBCWW) presso The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated public贸 un comunicado de prensa y una presentaci贸n para inversores con los resultados del trimestre cerrado el 30 de junio de 2025. El comunicado se incluye como Exhibit 99.1 y la presentaci贸n como Exhibit 99.2, estando la presentaci贸n disponible en la web de la compa帽铆a en https://sbc-holdings.com/en/ir/ir-presentation. El informe especifica que estos documentos son proporcionados, no presentados conforme al Exchange Act y, por tanto, no est谩n sujetos a las responsabilidades de la Secci贸n 18. La compa帽铆a se identifica como una emerging growth company y cotiza sus acciones ordinarias (SBC) y warrants redimibles (SBCWW) en The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated電� 2025雲� 6鞗� 30鞚茧 膦呺霅� 攵勱赴 鞁れ爜鞚� 鞎岆Μ電� 氤措弰鞛愲鞕� 韴瀽鞛� 頂勲爤鞝犿厡鞚挫厴鞚� 鞝滉车頄堨姷雼堧嫟. 氤措弰鞛愲電� Exhibit 99.1搿�, 頂勲爤鞝犿厡鞚挫厴鞚� Exhibit 99.2搿� 韽暔霅橃柎 鞛堨溂氅� 頂勲爤鞝犿厡鞚挫厴鞚� 須岇偓 鞗轨偓鞚错姼 https://sbc-holdings.com/en/ir/ir-presentation鞐愳劀霃� 頇曥澑頃� 靾� 鞛堨姷雼堧嫟. 氤搓碃靹滊姅 頃措嫻 鞛愲霌れ澊 Exchange Act鞐� 霐半澕 鞝滌稖霅� 瓴冹澊 鞎勲媹霛� 鞝滉车霅� 瓴�(furnished, not filed)鞙茧, 霐半澕靹� Section 18鞚� 毂呾瀯 雽�靸侅澊 鞎勲媹霛缄碃 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 鞀れ姢搿滊ゼ emerging growth company搿� 攴滌爼頃橂┌ 氤错喌欤�(SBC)鞕� 靸來櫂順� 鞗岆煱韸�(SBCWW)毳� The Nasdaq Stock Market LLC鞐� 靸侅灔頃橁碃 鞛堨姷雼堧嫟.
SBC Medical Group Holdings Incorporated a diffus茅 un communiqu茅 de presse et une pr茅sentation aux investisseurs faisant 茅tat des r茅sultats du trimestre clos le 30 juin 2025. Le communiqu茅 est inclus en tant que Exhibit 99.1 et la pr茅sentation en tant que Exhibit 99.2, la pr茅sentation 茅tant disponible sur le site de la soci茅t茅 脿 l'adresse https://sbc-holdings.com/en/ir/ir-presentation. Le rapport pr茅cise que ces 茅l茅ments sont communiqu茅s, non d茅pos茅s en vertu de l'Exchange Act et ne sont donc pas soumis aux responsabilit茅s pr茅vues par la Section 18. La soci茅t茅 se qualifie d'emerging growth company et inscrit ses actions ordinaires (SBC) ainsi que ses warrants remboursables (SBCWW) aupr猫s de The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated hat eine Pressemitteilung und eine Investorenpr盲sentation mit den Ergebnissen f眉r das Quartal zum 30. Juni 2025 ver枚ffentlicht. Die Pressemitteilung ist als Exhibit 99.1 und die Pr盲sentation als Exhibit 99.2 beigef眉gt; die Pr盲sentation ist zudem auf der Unternehmenswebsite unter https://sbc-holdings.com/en/ir/ir-presentation verf眉gbar. Der Bericht stellt klar, dass diese Unterlagen gem盲脽 dem Exchange Act zur Verf眉gung gestellt, nicht eingereicht wurden und daher nicht den Haftungsbestimmungen der Section 18 unterliegen. Das Unternehmen bezeichnet sich als emerging growth company und f眉hrt seine Stammaktien (SBC) sowie r眉ckzahlbare Warrants (SBCWW) an der The Nasdaq Stock Market LLC.
- None.
- None.
Insights
TL;DR The 8-K furnishes Q2 materials but contains no financial data in the filing itself, so investor impact is limited.
As provided, the filing supplies a press release and investor presentation for the quarter ended June 30, 2025, attached as Exhibits 99.1 and 99.2. The company explicitly states these materials are furnished rather than filed under the Exchange Act, which limits legal liability under Section 18. From the document alone there are no results or metrics to evaluate, so the filing functions as routine disclosure of investor materials rather than a material event.
Impact assessment: not impactful
TL;DR Routine disclosure of investor communications; governance implications minimal based on this filing alone.
The current report documents that a press release and an investor presentation concerning the quarter ended June 30, 2025 were furnished and tied to Exhibits 99.1 and 99.2. The filing also indicates the registrant is an emerging growth company and confirms securities trading symbols (SBC and SBCWW) on Nasdaq. Because the materials are furnished and not filed, the registrant limits incorporation and Section 18 exposure. No governance actions, officer changes, or material transactions are disclosed in this report.
Impact assessment: not impactful
SBC Medical Group Holdings Incorporated ha diffuso un comunicato stampa e una presentazione per gli investitori con i risultati del trimestre chiuso al 30 giugno 2025. Il comunicato 猫 incluso come Exhibit 99.1 e la presentazione come Exhibit 99.2, con la presentazione disponibile sul sito della societ脿 all'indirizzo https://sbc-holdings.com/en/ir/ir-presentation. Il rapporto specifica che questi documenti sono forniti, non depositati ai sensi dell'Exchange Act e pertanto non sono soggetti alle responsabilit脿 previste dalla Section 18. La societ脿 si identifica come emerging growth company e registra le proprie azioni ordinarie (SBC) e i warrant rimborsabili (SBCWW) presso The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated public贸 un comunicado de prensa y una presentaci贸n para inversores con los resultados del trimestre cerrado el 30 de junio de 2025. El comunicado se incluye como Exhibit 99.1 y la presentaci贸n como Exhibit 99.2, estando la presentaci贸n disponible en la web de la compa帽铆a en https://sbc-holdings.com/en/ir/ir-presentation. El informe especifica que estos documentos son proporcionados, no presentados conforme al Exchange Act y, por tanto, no est谩n sujetos a las responsabilidades de la Secci贸n 18. La compa帽铆a se identifica como una emerging growth company y cotiza sus acciones ordinarias (SBC) y warrants redimibles (SBCWW) en The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated電� 2025雲� 6鞗� 30鞚茧 膦呺霅� 攵勱赴 鞁れ爜鞚� 鞎岆Μ電� 氤措弰鞛愲鞕� 韴瀽鞛� 頂勲爤鞝犿厡鞚挫厴鞚� 鞝滉车頄堨姷雼堧嫟. 氤措弰鞛愲電� Exhibit 99.1搿�, 頂勲爤鞝犿厡鞚挫厴鞚� Exhibit 99.2搿� 韽暔霅橃柎 鞛堨溂氅� 頂勲爤鞝犿厡鞚挫厴鞚� 須岇偓 鞗轨偓鞚错姼 https://sbc-holdings.com/en/ir/ir-presentation鞐愳劀霃� 頇曥澑頃� 靾� 鞛堨姷雼堧嫟. 氤搓碃靹滊姅 頃措嫻 鞛愲霌れ澊 Exchange Act鞐� 霐半澕 鞝滌稖霅� 瓴冹澊 鞎勲媹霛� 鞝滉车霅� 瓴�(furnished, not filed)鞙茧, 霐半澕靹� Section 18鞚� 毂呾瀯 雽�靸侅澊 鞎勲媹霛缄碃 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 鞀れ姢搿滊ゼ emerging growth company搿� 攴滌爼頃橂┌ 氤错喌欤�(SBC)鞕� 靸來櫂順� 鞗岆煱韸�(SBCWW)毳� The Nasdaq Stock Market LLC鞐� 靸侅灔頃橁碃 鞛堨姷雼堧嫟.
SBC Medical Group Holdings Incorporated a diffus茅 un communiqu茅 de presse et une pr茅sentation aux investisseurs faisant 茅tat des r茅sultats du trimestre clos le 30 juin 2025. Le communiqu茅 est inclus en tant que Exhibit 99.1 et la pr茅sentation en tant que Exhibit 99.2, la pr茅sentation 茅tant disponible sur le site de la soci茅t茅 脿 l'adresse https://sbc-holdings.com/en/ir/ir-presentation. Le rapport pr茅cise que ces 茅l茅ments sont communiqu茅s, non d茅pos茅s en vertu de l'Exchange Act et ne sont donc pas soumis aux responsabilit茅s pr茅vues par la Section 18. La soci茅t茅 se qualifie d'emerging growth company et inscrit ses actions ordinaires (SBC) ainsi que ses warrants remboursables (SBCWW) aupr猫s de The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated hat eine Pressemitteilung und eine Investorenpr盲sentation mit den Ergebnissen f眉r das Quartal zum 30. Juni 2025 ver枚ffentlicht. Die Pressemitteilung ist als Exhibit 99.1 und die Pr盲sentation als Exhibit 99.2 beigef眉gt; die Pr盲sentation ist zudem auf der Unternehmenswebsite unter https://sbc-holdings.com/en/ir/ir-presentation verf眉gbar. Der Bericht stellt klar, dass diese Unterlagen gem盲脽 dem Exchange Act zur Verf眉gung gestellt, nicht eingereicht wurden und daher nicht den Haftungsbestimmungen der Section 18 unterliegen. Das Unternehmen bezeichnet sich als emerging growth company und f眉hrt seine Stammaktien (SBC) sowie r眉ckzahlbare Warrants (SBCWW) an der The Nasdaq Stock Market LLC.
FAQ
What did SBC (SBC) disclose in this 8-K?
Are the press release and presentation filed with the SEC?
Where can investors find the investor presentation for SBC?
What securities of SBC are registered for trading?
Does the 8-K indicate any executive changes or major transactions?
